The dedicated digital business of Hyphens Pharma — deploying digital health platforms across ASEAN.
DocMed Technology leads the digital arm of Hyphens Pharma International Limited. Incorporated in 2021 and headquartered in Singapore, we develop and operate our own digital health products serving multiple pharma partners in the region. We own our platforms, customers and roadmap with independent management of commercials and P&L — combining the agility of a technology company with the governance and heritage of a listed pharmaceutical group.
Specialty pharma and aesthetics distribution.
The Group's own consumer healthcare brands.
Led by DocMed Technology — platforms, data and AI.
Through our digital assets, pharmaceutical principals reach more healthcare professionals, HCPs deliver higher value services, and patients achieve better outcomes. We bring together Hyphens Group's strength in pharmaceutical distribution with cutting-edge software, data and AI — connecting pharma to healthcare professionals to patients.
Founder, CEO and Executive Director of Hyphens Group. With 30+ years of experience in the pharmaceutical industry, he drives Hyphens Group's regional expansion and commercial growth. He also leads the Group's vision to digitalize the healthcare value chain through DocMed Technology.
Our leadership combines pharmacists, technologists and commercial operators — people who have worked inside the healthcare system we are digitalizing.
One of the oldest and most established pharmaceutical wholesalers in Singapore — the foundation of trust we build on.
The Group goes public, with digitalization of the healthcare value chain as a strategic pillar.
Headquartered in Singapore as the dedicated digital arm of Hyphens Pharma.
Singapore's first HSA-registered e-pharmacy begins closed-loop e-prescription fulfilment.
Healthcare professionals and businesses adopt digitalization of procurement, medical education, and e-prescribing at scale.
Bringing decades of distribution heritage to modern digital health platforms across the region — with AI-powered features emerging as our next growth vector.
E-pharmacy services extended to Singapore's Primary Care Plan with SATA CommHealth.
POMACY launches, extending the marketplace to Malaysia.
WellAway integrates with clinic management systems.
Pharma AI Suite pilots begin with pharmaceutical principals.
Direct operations in Singapore and Malaysia, with the reach of the wider Hyphens Group across ASEAN and beyond. In Malaysia we operate as TechMed Sdn. Bhd., a wholly-owned subsidiary of DocMed Technology — the name our Malaysian partners know us by.
We believe digital health should serve everyone — not just the digitally connected. Our platforms are designed to make quality healthcare more accessible, affordable and convenient for the communities we serve.
Multilingual drug-allergy guide for migrant workers.
Through WellAway, DocMed partnered with SATA CommHealth — one of the anchor operators appointed under Singapore's Primary Care Plan for migrant workers — to deliver e-pharmacy medication after teleconsultation. To bridge language barriers, WellAway introduced multilingual pictograms alongside standard medication labels, helping patients understand and self-administer their medication safely, with phone counselling available when needed.
Our mission is to bring quality, affordable medication to the many — using the convenience and efficiency of digital pharmacy.
As part of Hyphens Pharma, our work aligns with the Group's sustainability commitments — reported annually in accordance with the Global Reporting Initiative (GRI) Standards — and its vision to provide a better quality of life for customers, employees and the community.
Hyphens' sustainability →Healthcare runs on trust. Every platform we build is designed to meet the standards expected of healthcare — from licensing to data protection and quality assurance.
DocMed is ISO/IEC 27001 certified and handles sensitive patient and HCP data with care — applying access controls, data safeguards and confidentiality measures aligned to the Personal Data Protection Act (PDPA) and HSA's e-pharmacy data requirements.
Compliant to GDP (HSA), GDPMDS (SS 620) and SS 644 requirements, including cold-chain integrity for temperature-sensitive products.
Documented quality systems, internal audits and full traceability across our e-pharmacy operations.
As a subsidiary of SGX-Catalist-listed Hyphens Pharma, we operate within the Group's corporate governance and compliance framework.